Recent biotechnology approvals.
Piascik
P
P
College of Pharmacy, University of Kentucky, Lexington, USA.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017277:Drug Approval; D005169:Factor VIII / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy; D007371:Interferon-gamma / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D010024:Osteoporosis / Q000188:drug therapy; D011994:Recombinant Proteins / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D007371:Interferon-gamma; D005169:Factor VIII